DSIJ Mindshare

The IPO of Creditaccess Gramin Limited opens for subscription from August 8 to August 10, 2018. This IPO consists of fresh equity issue worth Rs. 630 crore (1,49,28,910 shares) and offer for sale (OFS) of 1,18,76,485 shares by existing stakeholders. Post issue, promoter and promoter group’s holding will reduce to 80.3% and non-promoter shareholding will increase to 19.7% from 1.1%. The face value is Rs 10 per equity share. The minimum lot size is of 35 shares and the issue price band is Rs. 418-422 per equity share. Post allotment, the company will get listed on both BSE and NSE.

U.S. Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application for Ryaltris, an investigational fixed-dose combination nasal spray for seasonal allergic rhinitis (SAR) in patients 12 years of age and older.

As per the MoU, Genesys will develop HD Mapping and content by using its core strength and skills. Whereas, Wipro will develop the directional and controller technology for the autonomous system and smart mobility companies.

EBITDA for the quarter rose by 30.4 per cent yoy to Rs. 15.51 crore as against Rs. 11.89 crore in the corresponding quarter last year, with a corresponding margin expansion of 125 bps.

Following stocks are close to their 52-week low as at 12.44 p.m. on August 8, 2018.